arrow
V

Veerle M.H. Coupé

vrije universiteit amsterdam
H指数:43
被引数:6,233

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer

具有结直肠癌家族史个体的进展性新生物发展个性化风险估计

2026-05-140
OA
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study
2026-01-013
PRE
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness

CtDNA指导下的辅助化疗降级治疗在III期结肠癌中的应用:基于模型的早期成本效益评估

2025-11-060
OA
Efficacy and Budget Impact of a Tailored Psychological Intervention Program Targeting Cancer Patients With Adjustment Disorder: A Randomised Controlled Trial

针对伴有适应障碍的癌症患者的个性化心理干预方案的疗效与预算影响:一项随机对照试验

2025-03-010
OAAI
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

ctDNA指导的 ⅱ 期结肠癌辅助化疗选择的有效性和成本-效果的早期评价

2024-08-212
OAAI
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting

在筛查环境中,粪便中聚酮化合物合酶阳性大肠杆菌的一次性测量不能提供结直肠癌风险的信息

2024-03-290
OA
Monitoring treatment response in patients with metastatic colorectal cancer using cfDNA fragmentomics testing: The DOLPHIN trial
2024-03-220
PRE
Clinical validity of post-surgery circulating tumor DNA testing in stage III colon cancer patients treated with adjuvant chemotherapy: The PROVENC3 study
2024-03-220
PRE
MEDOCC-CrEATE trial: Feasibility of measuring circulating tumor DNA after surgery to guide adjuvant chemotherapy in stage II colon cancer patients
2024-03-220
PRE
Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial
2023-09-071
OAAI